Kim et al. (2018) transduced human regulatory T cells with a myelin-basic protein-specific TCR isolated from an MS patient and demonstrated that the MBP-specific regulatory T cells suppressed MBP-specific effector cells in vitro and ameliorated disease in a mouse model of MS. This evidence concerns the gene MBP and myeloid sarcoma.